profile

T2B Monthly

Featured Post

T2B Monthly | August 2026

T2B Monthly | August 2026 Hi! What. A. Summer. It’s been a bit of a roller coaster, and somehow we’re already gearing up for fall (and JPM). September brings a full slate of T2Bmeets, and in November, we’ll be back in London during Jefferies. Lots ahead, and I’m glad you’re along for it. Today's email is 2,640 words, a 9-minute read. In this edition 🗓️ T2B programming snapshot 🎥 ICYMI: Recent event replays 🤖 Scoping Your First Agentic Workflow @ 2nd Annual Virtual Biopharma Comms Forum 🏛️...

Hi! Throughout the summer, we’ve taken you inside the findings from our inaugural AI in Biopharma Comms Survey, developed through the T2B AI Roundtable with Knowledge Partner Syneos Health Communications. There were five big takeaways (full report here), and today we’re taking a closer look at #3: access, governance, and trust are uneven. The short version: guidance exists in many organizations, but guidance alone doesn’t create confidence. As AI becomes part of everyday comms work, many...

Hi! In our July Comm Convo -- led by BioPharma Dive reporter Gwen Wu -- our panelists, Chloe Kirk, Ph.D. (BiotechTV), Ben McLeod (Convey Bio + The Biotech Voyager), and Liz Puzio (Simtra BioPharma Solutions), discussed how we can help scientists and executives communicate with more credibility without over-managing what they say. Our top 10 takeaways from Why Only Some Platforms Are Trusted When Everyone Has One: 1. Separate the executive from the corporate microphone. Trust slips for leaders...

Hi! Regardless if patient advocacy is in your or your clients' remit, we communicators still work with patients and patient advocacy organizations all the time -- from storytelling and disease education to advisory boards, clinical trial communications, research initiatives, employee engagement, and beyond. But the role of patient advocacy has evolved, and so should the way we approach those relationships. Tomorrow’s Comm Convo will bring together leaders from the Cystic Fibrosis Foundation,...

Hi! Although our T2B programming is purposeful and tailored to biopharma communicators, we know it's almost impossible to attend and read everything we put out for the community. Instead, we hope that a subset of what we offer really resonates with you and serves where you're at -- wherever that is. Tomorrow, I'm holding a short, 30-minute info session to walk through the different kinds of membership and how to maximize your experience. T2B Info Session Tuesday, August 25th (tomorrow)12:30-1...

Hi! Registration is officially open for our 2nd Annual Virtual Biopharma Comms Forum, happening Tuesday, October 6th and Wednesday, October 7th. This year’s theme is Owning the Outcome. The title reflects how much our jobs have been changing. The comms role has expanded across the business – into investor relations, policy, patient advocacy, employee engagement, digital, social, AI, and beyond. While few of us formally own ALL of these areas, we are increasingly expected to understand how...

Hi! We’ve got a full stretch of in-person gatherings coming up next month, and we can't wait to reconnect with many of you IRL for a mix of networking, conversation, and community. T2Bmeet @ Washington, D.C. | Tuesday, September 15th | 5:30-8 p.m. ET Little Coco's (Petworth, just north of Columbia Heights) Our second annual T2Bmeet @ D.C. is the first stop on our East Coast tour. Hope you can swing by after work to say hello, any time between 5:30 and 8 p.m. Complimentary apps will be...

Hi! In one week, T2B is bringing together several patient advocacy leaders for a candid conversation about what patients are asked to contribute—and the terms of those exchanges. Regardless of whether patient advocacy is formally in your remit, we communicators work with patients and caregivers regularly to share their experiences through corporate campaigns, employee events, advisory boards, focus groups, clinical development initiatives, and more. Our August Comm Convo will explore how we...

Hi! At our Q2 Media Minds Roundtable event, From Newsroom to Newsletter: Why Healthcare’s Top Journalists Are Going Independent, we brought together three experienced healthcare journalists who left traditional newsrooms to build reporting platforms of their own. Our panelists – Sharon Goldman (Ground Level AI, formerly of Fortune), Liz Kelly Nelson (Project C, formerly of Washington Post, Vox, USA Today, Gannett, and AOL), and Tara Parker-Pope (One Day Better Inc., formerly of the New York...

Hi! Applications are now open for three spots on the T2B AI Roundtable as the group enters its second year. During its inaugural year, the AI Roundtable helped our community stay at the forefront of a technology that is quickly reshaping what it means to be a corporate affairs practitioner. This roundtable led our annual AI in Biopharma Communications Survey, developed practical monthly resources, and shaped some of T2B’s most popular webinars. In year two, the group will build on that...